Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.0099 | 1 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |